ARDELYX INC. - COMMON STOCK
4.4450
14-November-24 10:59:32
15 minutes delayed
Stocks
-0.0550
-1.22%
Today's range
4.4300 - 4.5800
ISIN
N/A
Source
NASDAQ
-
Ardelyx, Inc. Reports Employment Inducement Grants
30 Oct 2023 17:42:57 By Nasdaq GlobeNewswire
-
23 Oct 2023 08:07:01 By Nasdaq GlobeNewswire
-
Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023
18 Oct 2023 16:02:39 By Nasdaq GlobeNewswire
-
17 Oct 2023 19:23:38 By Nasdaq GlobeNewswire
-
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
17 Oct 2023 19:01:06 By Nasdaq GlobeNewswire
-
13 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
28 Sep 2023 08:02:00 By Nasdaq GlobeNewswire
-
Tenapanor for Hyperphosphatemia Approved in Japan
25 Sep 2023 04:15:13 By Nasdaq GlobeNewswire
-
11 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
07 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
02 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
27 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
26 Jul 2023 07:55:00 By Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
20 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
13 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
29 Jun 2023 16:09:08 By Nasdaq GlobeNewswire
-
05 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
31 May 2023 08:00:00 By Nasdaq GlobeNewswire